Medication info

Olmesartan 40 mg Tablet (Olmesartan Medoxomil)

Prescription medicationTabletOralExpired
Ingredient · strength
Olmesartan Medoxomil›40mg / 1 tablet
Manufacturer / importer
Donggu Bio Pharmaceutical Co., Ltd.
Appearance
White oblong film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Expired

MFDS item code 201906476 · Approved 2019.09.17

This product's status changed to Expired on 2024.09.17. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of essential hypertension
Who takes it
Adults · Children
Adult dose
<Adults> The recommended initial dose is 10mg once daily, with or without food. If blood pressure is not adequately controlled at this dose, increase to 20mg once daily. If further blood pressure reduction is required, the dose may be increased to a maximum of 40mg daily. The blood pressure-lowering effect appears within 2 weeks after starting treatment and reaches its maximum after approximately 8 weeks. If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the medicine be taken at the same time each day (e.g., in the morning), if possible. In patients who may have reduced effective intravascular volume (e.g., patients taking diuretics, especially those with renal impairment), treatment should be started at a low dose with close monitoring of their condition. <Elderly patients> No dosage adjustment is necessary when this medicine is administered to patients 65 years of age or older. <Patients with renal impairment> The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dosage adjustment is necessary in patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, and may be increased to a maximum of 20mg daily. Since there is no experience with use in patients with severe hepatic impairment, administration of this medicine is not recommended.
Child dose
Safety and efficacy in pediatric patients have not been established.

Ingredients

Manufacturer
Donggu Bio Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension

  • Essential hypertension
View approved original text

Essential hypertension refers to a persistent increase in blood pressure without a specific cause. This medication helps control blood pressure, thereby reducing the burden on the heart and blood vessels. By managing hypertension, it lowers the risk of cardiovascular complications such as stroke and myocardial infarction. Consistent treatment combined with lifestyle modifications is important, and this medication is used for the treatment of essential hypertension.

How to take

Adult dose

<Adults> The recommended initial dose is 10mg once daily, with or without food. If blood pressure is not adequately controlled at this dose, increase to 20mg once daily. If further blood pressure reduction is required, the dose may be increased to a maximum of 40mg daily. The blood pressure-lowering effect appears within 2 weeks after starting treatment and reaches its maximum after approximately 8 weeks. If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the medicine be taken at the same time each day (e.g., in the morning), if possible. In patients who may have reduced effective intravascular volume (e.g., patients taking diuretics, especially those with renal impairment), treatment should be started at a low dose with close monitoring of their condition. <Elderly patients> No dosage adjustment is necessary when this medicine is administered to patients 65 years of age or older. <Patients with renal impairment> The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dosage adjustment is necessary in patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, and may be increased to a maximum of 20mg daily. Since there is no experience with use in patients with severe hepatic impairment, administration of this medicine is not recommended.

Child dose

Safety and efficacy in pediatric patients have not been established.

Precautions

This medication can cause serious harm or death to the fetus or newborn if taken during the second and third trimesters of pregnancy; therefore, it must be discontinued immediately once pregnancy is confirmed. Individuals allergic to any components of this medication, including pregnant or breastfeeding women, should not take it. Patients undergoing renal dialysis, those with severe liver dysfunction, and those with biliary obstruction should not use this medication. Patients with lactose intolerance or specific genetic disorders should not be administered this medication due to the lactose component it contains. Patients with reduced blood volume or sodium levels should monitor their condition carefully, as symptoms of hypotension may occur in the early stages of treatment with this medication. Patients with weakened kidney function or those who have received kidney transplants should regularly check potassium and creatinine levels, and it is not recommended for patients with severe renal impairment. Due to the risk of hyperkalemia, patients with heart failure or poor kidney function should frequently test their potassium levels. Dizziness and other symptoms may occur, so it is advisable to avoid dangerous activities such as working at heights or driving. The blood pressure-lowering effect may increase when this medication is used alongside other antihypertensives, so it's essential to inform healthcare providers of any medications being taken. Caution is warranted when taking potassium-sparing diuretics or potassium supplements as they can dangerously elevate serum potassium levels. When combined with lithium, lithium levels may rise, leading to toxicity; therefore, it is advisable not to use them together. Co-administration with non-steroidal anti-inflammatory drugs may worsen renal function, necessitating increased fluid intake and regular renal function checks. Taking this medication during pregnancy can lead to serious adverse effects such as impaired renal development of the fetus, decreased amniotic fluid, and cranial development disorders. Breastfeeding women should discontinue this medication or stop breastfeeding since this drug can pass into breast milk and may cause adverse reactions in infants. Safety and efficacy in pediatric patients have yet to be established, so it is advisable not to administer this medication to children. In cases of overdose, symptoms such as hypotension, palpitations, and bradycardia may occur, requiring immediate medical attention. While long-term use of this medication has been reported to have a low risk of carcinogenicity or genotoxicity, any abnormal symptoms during treatment should prompt immediate consultation with healthcare professionals.

Side effects

  • Dizziness
  • low back pain
  • bronchitis
  • increased creatine phosphokinase
  • diarrhea
  • headache
  • hematuria
  • hyperglycemia
  • hypertriglyceridemia
  • influenza-like symptoms
Show 36 more
  • pharyngitis
  • rhinitis
  • sinusitis
  • cough
  • chest pain
  • peripheral edema
  • vertigo
  • abdominal pain
  • dyspepsia
  • gastritis
  • nausea
  • palpitations
  • hypercholesterolemia
  • hyperlipidemia
  • hyperuricemia
  • arthralgia
  • arthritis
  • myalgia
  • rash
  • facial edema
  • asthenia
  • angioedema
  • anaphylaxis
  • vomiting
  • chronic malabsorption syndrome
  • rhabdomyolysis
  • hyperkalemia
  • acute renal failure
  • elevated serum creatinine
  • hair loss
  • pruritus
  • urticaria
  • autoimmune hepatitis
  • hypertension
  • epistaxis
  • asthma

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. The storage temperature should be maintained at room temperature between 1 and 25 degrees Celsius.

Appearance and packaging

Appearance

White oblong film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.